• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $TLRY

    Tilray Brands Inc.

    Subscribe to $TLRY
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.

    IPO Year: 2018

    Exchange: NASDAQ

    Website: tilray.com

    Recent Analyst Ratings for Tilray Brands Inc.

    DatePrice TargetRatingAnalyst
    4/5/2024$2.25 → $2.75Neutral
    Alliance Global Partners
    11/2/2022$3.90Mkt Perform
    Bernstein
    7/29/2022$3.00Hold → Sell
    The Benchmark Company
    3/4/2022$9.00Hold → Buy
    Canaccord Genuity
    1/11/2022$7.40 → $6.90Neutral
    Cantor Fitzgerald
    1/7/2022$11.80 → $7.40Neutral
    Cantor Fitzgerald
    11/18/2021$10.00Underweight
    Barclays
    11/1/2021$18.00 → $11.80Overweight → Neutral
    Cantor Fitzgerald
    10/8/2021$14.00 → $12.00Neutral
    CIBC
    9/17/2021$19.00 → $18.00Overweight
    Cantor Fitzgerald
    See more ratings

    Tilray Brands Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Shock Top: A Bold Rebrand for a Craft Beer Icon

      PORTLAND, Ore., May 08, 2025 (GLOBE NEWSWIRE) -- Shock Top, a craft beer icon and brand by Tilray Brands, Inc. company (NASDAQ:TLRY, TSX:TLRY), known for its bold flavors and unfiltered wheat ales, today announced a transformative rebrand. With revamped packaging, a new logo, and an expanded, integrated marketing campaign, Shock Top aims to shock a new generation of beer drinkers with a modern look and shocking new seasonal flavors. Building on its legacy of delivering exceptional beers, Shock Top's rebrand introduces a completely new visual identity that enhances its personality and offers a unique experience with every flavor. The new Wedgehead icon is designed as a bolder and more cont

      5/8/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Blue Point Brewing Co. Announces the Return of Delayed Pilsner

      PATCHOGUE, N.Y., May 06, 2025 (GLOBE NEWSWIRE) -- Blue Point Brewing Co., a Tilray Brands, Inc., (NASDAQ:TLRY, TSX:TLRY) craft beer brand, announces the highly anticipated re-release of Delayed Pilsner, a beer crafted to soothe the soul of every New Yorker facing the inevitable delays of city life. Whether it's 2 minutes or 2 hours, delays are scientifically proven to be the bane of any New Yorker's existence. But fear not, Blue Point Brewing has brewed the ultimate lager to get you through this abomination. Delayed Pilsner is brewed with a blend of floral, spicy hops that impart subtle apple and lemon-lime aromas. Balanced by slight honey notes from a creamy malt body, the result is a

      5/6/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • 10 Barrel Brewing Launches Non-Alcoholic Apocalypse IPA, a Bold Craft Brew for Your Next Adventure

      BEND, Ore., April 30, 2025 (GLOBE NEWSWIRE) -- 10 Barrel Brewing, a Tilray Brands, Inc., (NASDAQ:TLRY, TSX:TLRY) craft beer brand, is excited to announce the launch of NA Apocalypse IPA, a non-alcoholic version of their beloved Apocalypse IPA. This new offering delivers the same bold, hop-driven flavor that fans have come to love, now without the alcohol. NA Apocalypse IPA is crafted with the same big flavor to provide the signature punch of pine, citrus, and tropical notes that define the original IPA, minus the alcohol. Whether you're winding down at the end of the day or gearing up for a new adventure, NA Apocalypse IPA offers a taste that's big on hops and light on compromise. "We

      4/30/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Widmer Brothers Brewing Celebrates 40th Anniversary

      PORTLAND, Ore., April 28, 2025 (GLOBE NEWSWIRE) -- Widmer Brothers Brewing, the creator of the Original American Hefeweizen and a Tilray Brands, Inc., (NASDAQ:TLRY, TSX:TLRY) craft beer brand, commemorates its 40th anniversary with the launch of the "40 Years of Cheers" campaign celebrating Widmer's iconic beers through the years. This multi-stage celebration marks the brewery's 40th anniversary and will feature the re-release of four iconic Widmer Brothers beers. The "40 Years of Cheers" campaign will kick off with the re-release of Altbier, the first beer brewed and sold by Widmer Brothers in 1984. Altbier is a traditional German-style ale known for its amber hue, assertive bitterness

      4/28/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Forget Sugary Sodas Wellness Drinks Are Gaining Ground With Consumers and Investors

      Equity Insider News Commentary Issued on behalf of Safety Shot, Inc. VANCOUVER, B.C., April 25, 2025 /PRNewswire/ -- Equity Insider News Commentary – The way people consume beverages is changing, both in terms of what they're drinking and how they're buying it. Functional and fortified drinks are gaining ground, with analysts at Insight Ace Analytic forecasting the category to grow at a 7.9% annual rate through 2035. Industry watchers now consider functional beverages one of the fastest-expanding segments within the broader wellness market. This shift hasn't gone unnoticed by investors, especially as companies across the sector continue to roll out new products and strategies to capture dema

      4/25/25 3:22:00 PM ET
      $FIZZ
      $KO
      $PEP
      $SHOT
      Beverages (Production/Distribution)
      Consumer Staples
      Package Goods/Cosmetics
      Consumer Discretionary
    • Terrapin Beer Co. Celebrates 23 Years of Craft Beer and Environmental Stewardship with Terraprint Initiative and Orvis Partnership

      ATHENS, Ga., April 24, 2025 (GLOBE NEWSWIRE) -- Terrapin Beer, a leading craft brewery known for its innovative and high-quality beers and a Tilray Brands, Inc., craft beer brand (NASDAQ:TLRY, TSX:TLRY), is thrilled to partner with Orvis, the renowned outdoor retailer and fly-fishing expert. The two companies initially kicked off this partnership in 2024 as part of Terrapin's Terraprint initiative, which has objectives to minimize the brewery's impact on the environment and maximize its impact in the community. This collaboration aims to celebrate the spirit of adventure and the great outdoors, bringing together two brands committed to sustainability and community engagement. Terrapin i

      4/24/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Breckenridge Distillery Announces Re-Release of Award-Winning Cognac Cask Finish Whiskey

      BRECKENRIDGE, Colo., April 23, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, one of the most-awarded craft distilleries in the U.S., and a Tilray Brands, Inc., (NASDAQ:TLRY, TSX:TLRY) spirits brand, today announced its newest addition to the brand's line of cask finish whiskeys, Breckenridge Cognac Cask Finish. Initially launched as a limited edition in the second Collectors Art Series at the distillery's Breckenridge location in 2022, this whiskey is now available in Colorado with national expansion planned in the coming months. Photo Courtesy: Jessie Unruh, Breckenridge Distillery Cognac is produced with well-known grapes from regions in France. A fine Cognac is 15 perc

      4/23/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Beverages Launches Cruisies, a New Line of Ready-To-Drink Cocktails

      NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Beverages, the U.S. beverage division of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY) announces the introduction of Cruisies, a new line of refreshing, ready-to-drink cocktails designed to enhance summer vibes. Cruisies' initial product lineup includes: Blood Orange Vodka Soda: The vibrant zest of blood orange is expertly blended with smooth vodka to create a refreshing beverage suitable for any occasion.Golf Tea: The perfect blend of smooth vodka, refreshing tea, and tart lemonade. A non-carbonated delight designed for relaxation on or off the course.Cuba Libre: The classic taste of a rich rum, crisp cola, and a hint of lime for

      4/17/25 8:30:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Medical Introduces Cannabis Edibles in Australia

      SYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), a division of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, has announced the availability of its medical cannabis edibles, Good Supply Pastilles, to patients in Australia. This launch marks Tilray Medical's first medical cannabis edible offering in the country, providing patients with a sugar-free and vegan-friendly treatment option. Denise Faltischek, Chief Strategy Officer and Head of International, Tilray Brands, stated, "Our dedication to innovati

      4/17/25 8:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders

      NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced a special meeting of stockholders (the "Special Meeting") on June 10, 2025. The Special Meeting will be held via live audio webcast, which can be accessed on the investor page on Tilray.com. At the Special Meeting, stockholders will be asked to vote for an amendment of the Company's Fifth Amended and Restated Certificate of Incorporation, in order to implement a reverse stock split of the Company's common stock at a rati

      4/17/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    Tilray Brands Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Cohen Steven Michael

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/8/25 4:16:07 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • New insider Cohen Steven Michael claimed no ownership of stock in the company (SEC Form 3)

      3 - Tilray Brands, Inc. (0001731348) (Issuer)

      12/17/24 4:05:56 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Chief Financial Officer Merton Carl A bought $35,360 worth of shares (26,000 units at $1.36) (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      11/18/24 11:29:05 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • President and CEO Simon Irwin D exercised 706,214 shares at a strike of $2.03 and covered exercise/tax liability with 390,537 shares, increasing direct ownership by 11% to 3,246,484 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      8/2/24 4:08:46 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Chief Financial Officer Merton Carl A exercised 93,926 shares at a strike of $2.03 and covered exercise/tax liability with 43,357 shares, increasing direct ownership by 8% to 660,055 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      8/2/24 4:08:13 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Global General Counsel Gendel Mitchell exercised 93,926 shares at a strike of $2.03 and covered exercise/tax liability with 47,950 shares, increasing direct ownership by 12% to 420,268 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      8/2/24 4:07:41 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Chief Strategy Officer Faltischek Denise M exercised 93,926 shares at a strike of $2.03 and covered exercise/tax liability with 47,950 shares, increasing direct ownership by 9% to 535,693 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      8/2/24 4:06:55 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • President and CEO Simon Irwin D covered exercise/tax liability with 54,302 shares and exercised 98,194 shares at a strike of $1.83, increasing direct ownership by 2% to 2,930,807 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      7/30/24 6:35:38 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 4 filed by Director Persofsky Renah

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      7/30/24 6:35:16 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Chief Financial Officer Merton Carl A exercised 12,166 shares at a strike of $1.83 and covered exercise/tax liability with 5,616 shares, increasing direct ownership by 1% to 609,486 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      7/30/24 6:34:57 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    Tilray Brands Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more

    Tilray Brands Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Chief Financial Officer Merton Carl A bought $35,360 worth of shares (26,000 units at $1.36) (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      11/18/24 11:29:05 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Faltischek Denise M bought $20,500 worth of shares (10,000 units at $2.05), increasing direct ownership by 4% to 293,269 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/18/24 8:32:10 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Gendel Mitchell bought $14,256 worth of shares (7,200 units at $1.98), increasing direct ownership by 4% to 195,796 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/16/24 1:07:47 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Gendel Mitchell bought $10,098 worth of shares (5,400 units at $1.87), increasing direct ownership by 3% to 188,596 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/12/24 3:39:01 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Simon Irwin D bought $100,956 worth of shares (53,700 units at $1.88), increasing direct ownership by 3% to 2,033,058 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/12/24 3:36:49 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Merton Carl A bought $37,400 worth of shares (20,000 units at $1.87) (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/12/24 3:36:08 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Alliance Global Partners reiterated coverage on Tilray with a new price target

      Alliance Global Partners reiterated coverage of Tilray with a rating of Neutral and set a new price target of $2.75 from $2.25 previously

      4/5/24 7:39:50 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Bernstein initiated coverage on Tilray with a new price target

      Bernstein initiated coverage of Tilray with a rating of Mkt Perform and set a new price target of $3.90

      11/2/22 6:37:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray downgraded by The Benchmark Company with a new price target

      The Benchmark Company downgraded Tilray from Hold to Sell and set a new price target of $3.00

      7/29/22 7:19:40 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray upgraded by Canaccord Genuity with a new price target

      Canaccord Genuity upgraded Tilray from Hold to Buy and set a new price target of $9.00

      3/4/22 6:10:38 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cantor Fitzgerald reiterated coverage on Tilray with a new price target

      Cantor Fitzgerald reiterated coverage of Tilray with a rating of Neutral and set a new price target of $6.90 from $7.40 previously

      1/11/22 4:39:43 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cantor Fitzgerald reiterated coverage on Tilray with a new price target

      Cantor Fitzgerald reiterated coverage of Tilray with a rating of Neutral and set a new price target of $7.40 from $11.80 previously

      1/7/22 4:42:16 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Barclays initiated coverage on Tilray with a new price target

      Barclays initiated coverage of Tilray with a rating of Underweight and set a new price target of $10.00

      11/18/21 5:10:04 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray downgraded by Cantor Fitzgerald with a new price target

      Cantor Fitzgerald downgraded Tilray from Overweight to Neutral and set a new price target of $11.80 from $18.00 previously

      11/1/21 7:50:22 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • CIBC reiterated coverage on Tilray with a new price target

      CIBC reiterated coverage of Tilray with a rating of Neutral and set a new price target of $12.00 from $14.00 previously

      10/8/21 7:28:21 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cantor Fitzgerald reiterated coverage on Tilray with a new price target

      Cantor Fitzgerald reiterated coverage of Tilray with a rating of Overweight and set a new price target of $18.00 from $19.00 previously

      9/17/21 4:45:40 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    Tilray Brands Inc. Leadership Updates

    Live Leadership Updates

    See more
    • Terrapin Beer Co. Celebrates 20 Years of Iconic Wake-n-Bake Beer with Exciting Wake-n-Bake Off Event in Athens, GA

      ATHENS, Ga., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Terrapin Beer Co., a Tilray Beverages craft beer brand under Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), is excited to announce the 20th anniversary of its Wake-n-Bake Coffee Oatmeal Imperial Stout seasonal beer and the annual Wake-n-Bake Off event on Sunday, January 26th, 2025, at the Terrapin taproom in Athens, GA. In celebration of its 20th anniversary, guests will have the chance to observe local restaurants competing to craft the finest dish featuring Terrapin's renowned Wake-n-Bake Beer. This event highlights culinary innovation and fosters community engagement through an array of sweet and savory tastings that showcase the rich flavor

      1/23/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Blue Point Brewing Launches Big Mo Brew to Raise Funds and Awareness for Men's Health During Movember

      PATCHOGUE, N.Y., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island's original craft brewery and subsidiary of Tilray Brands, (NASDAQ:TLRY, TSX:TLRY), is proud to announce the continuation of its men's health awareness campaign in support of Movember. The month shines a light on key men's health issues—mental health, prostate cancer, and testicular cancer—encouraging open conversations and proactive engagement. To honor the initiative, Blue Point Brewing announced the special release of its classic double IPA, Big Mo, available at our brewery and retailers in Long Island, New York. This hazy double IPA, featuring prominent mosaic hops and an ABV of 8.0%, proud

      10/22/24 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Breckenridge Brewery Opens New Location in Fort Collins, Colorado

      FORT COLLINS, Colo., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a Colorado-based craft brewer with over 30 years of experience brewing approachable, well-balanced beers, announces the opening of its new brewery location in Fort Collins. With doors opening in early August 2024, the new 10,000-square-foot Breckenridge Brewery offers a full restaurant experience and a new vibrant atmosphere in the heart of Fort Collins for all to enjoy. The new location will be a full-service restaurant, upholding the Breckenridge Brewery legacy while ushering in new opportunities for innovation and community collaboration. With a menu boasting a diverse range of culinary delights designed to co

      8/5/24 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Twist Your Tastebuds Three Ways: Good Supply Cannabis Brand Launches 'Twisted' All-In-One Vapes

      TORONTO, May 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced the highly anticipated Good Supply® ‘Twisted' All-In-One ("AIO") Vapes hitting the market, offering a revolutionary way to experience its delicious vape flavours. With the ability to switch between complimentary flavours or combining them for a "twist" – creating a unique third flavour experience of the two flavours enjoyed together, Good Supply has a jam packed vape with a series of unique flavour possibilities all-in-one, ready to go for consumers looking for variety that packs a punch. With the new Twisted All-in-One vape

      5/30/24 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Redhook Brewery Announces New "Big Juicy Ballard" IPA and Revives IPA Daze Festival at the Brewlab on 4/20 Weekend

      SEATTLE, April 03, 2024 (GLOBE NEWSWIRE) -- Redhook Brewery, makers of pure Pacific Northwest ale, and a subsidiary of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), is introducing the brewery's newest offering: Big Juicy Ballard IPA, a higher ABV, high-octane juice bomb bursting with tropical hops and a lingering sweet finish, hitting shelves this April. Redhook's Big Ballard family pays homage to its original stomping grounds in the Ballard District where Redhook was born in 1981 and builds on the resounding success of our beloved Big Ballard series—featuring the Original, Hazy, and Tropical variations. We proudly introduce the newest member: Big Juicy Ballard. With an impressive ABV of 9

      4/3/24 8:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • MedMen Announces Ana Bowman as Permanent CFO

      MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE:MMEN) (OTCQX:MMNFF), a premier cannabis retailer with operations across the United States, today announced the appointment of Ana Bowman as Chief Financial Officer, effective February 22, 2022. Bowman succeeds outgoing interim CFO Reece Fulgham, who will be returning to consulting firm SierraConstellation Partners. Bowman brings years of cannabis industry expertise, having served as Vice President of Financial Reporting and FP&A of Tilray Brands (NASDAQ:TLRY, TSX:TLRY), a leading global cannabis lifestyle and consumer packaged goods company. Prior to joining Tilray, Bowman served as Corporate Controller of several publicly-traded U.S

      2/18/22 5:39:00 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Strengthens Leadership Position in Canada

      Blair MacNeil, Former Bacardi General Manager, Joins Tilray to Lead the Company's Canadian Growth Strategy Tilray, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY) announces the expansion of its leadership team with the appointment of Blair MacNeil as President, Tilray Canada. In his new role, Blair will drive Tilray's next stage of growth in Canada and oversee sales, marketing, and operations across medical and adult-use cannabis businesses. Blair will report to Jim Meiers, who has been appointed to Chief Operations Officer, Tilray, Inc. Irwin D. Simon, Chairman and Chief Executive Officer, stated, "Blair MacNeil has a proven track record in driving accelerated growth for indust

      10/19/21 7:30:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original "Shark" from the NBC hit TV series "Shark Tank" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria

      VANCOUVER, BC, Aug. 31, 2021 /PRNewswire/ - Hollister Biosciences Inc. (CSE:HOLL) (OTC:HSTRF) (FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") is pleased to announce the appointment of two new members to its Board of Directors: Mr. Kevin Harrington and Mr. Jakob Ripshtein. Mr. Kevin Harrington is a veteran CEO, bestselling author and platform-building entrepreneur known to millions as one of the original "sharks" on the 4x Emmy-winning ABC series Shark Tank. His many landmark achievements include inventing the infomercial, pioneering the As Seen on TV brand, co-founding the Electronic Retailers Association (ERA), serving as a co-founding board member of the Entrepr

      8/31/21 8:00:00 AM ET
      $CELH
      $TLRY
      Beverages (Production/Distribution)
      Consumer Staples
      Medicinal Chemicals and Botanical Products
      Health Care
    • High Tide Announces Addition to the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) and Results of Annual General Meeting

      High Tide Inc. ("High Tide" or the "Company") (TSXV:HITI) (NASDAQ:HITI) (FRA: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, today announced that as per the recently disclosed listing of holdings available on its website, the Company's shares have now been included in Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ). "We are very pleased to have our shares included in the Horizons Marijuana Life Sciences Index ETF," said Raj Grover, President and Chief Executive Officer of High Tide. "This is yet more recognition of High Tide's continued execution which has now resulted in another high profile institution acquiri

      7/30/21 6:05:00 AM ET
      $TLRY
      $HITI
      $ACB
      Medicinal Chemicals and Botanical Products
      Health Care
      Other Specialty Stores
      Consumer Discretionary
    • High Tide Announces Addition to the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ ) and Results of Annual General Meeting

      CALGARY, AB, July 30, 2021 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (TSXV:HITI) (NASDAQ:HITI) (FRA: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, today announced that as per the recently disclosed listing of holdings available on its website, the Company's shares have now been included in Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ). "We are very pleased to have our shares included in the Horizons Marijuana Life Sciences Index ETF," said Raj Grover, President and Chief Execu

      7/30/21 6:00:00 AM ET
      $TLRY
      $ACB
      $HITI
      Medicinal Chemicals and Botanical Products
      Health Care
      Other Specialty Stores
      Consumer Discretionary

    Tilray Brands Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Tilray Brands Inc. (Amendment)

      SC 13G/A - Tilray Brands, Inc. (0001731348) (Subject)

      2/13/23 1:34:44 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G filed by Tilray Brands Inc.

      SC 13G - Tilray Brands, Inc. (0001731348) (Subject)

      2/10/23 4:41:36 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D filed by Tilray Brands Inc.

      SC 13D - Tilray Brands, Inc. (0001731348) (Filed by)

      7/22/22 4:30:22 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D filed by Tilray, Inc.

      SC 13D - Tilray, Inc. (0001731348) (Filed by)

      12/17/21 4:40:18 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed by Tilray, Inc. (Amendment)

      SC 13D/A - Tilray, Inc. (0001731348) (Subject)

      5/25/21 5:03:22 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed

      SC 13D/A - Tilray, Inc. (0001731348) (Subject)

      2/16/21 4:16:09 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed

      SC 13D/A - Tilray, Inc. (0001731348) (Subject)

      2/16/21 4:05:42 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed

      SC 13D/A - Tilray, Inc. (0001731348) (Subject)

      2/16/21 4:02:05 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - Tilray, Inc. (0001731348) (Subject)

      2/16/21 11:12:08 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - Tilray, Inc. (0001731348) (Subject)

      2/16/21 10:08:34 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    Tilray Brands Inc. Financials

    Live finance-specific insights

    See more
    • Tilray Brands Reports Q3 Fiscal 2025 Financial Results

      Tilray Confirms No Current Impact of Tariffs Generated Net Revenue of $186 Million in the Third Quarter, $193 Million in Constant Currency; Strategic Initiatives and SKU Rationalization Impacted Revenue by $13 Million Tilray Beverage Expands U.S. Distribution of Hemp-Derived THC Drinks Across 10 States, Increases Project 420 Cost Savings Plan to $33 Million Tilray Cannabis Increased Gross Margins by 800 bps, Remains the Leader in Canada by Sales Performance, and Generates Strong Sales Growth in Germany Strengthens Balance Sheet with Convertible Note Reduction of $58 Million and Total Debt Reduction of $71 Million, $248 Million Available in Cash and Marketable Securities NEW Y

      4/8/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands, Inc. to Announce Third Quarter Fiscal 2025 Financial Results on April 8, 2025

      NEW YORK and LEAMINGTON, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced that the Company will release financial results for its third quarter fiscal 2025 ended February 28, 2025 before financial markets open on April 8, 2025. Live Conference Call and Audio Webcast Tilray will hold a live conference call, which will be webcast, to discuss these results at 8:30 a.m. Eastern Time. The webcast can be accessed in the Investors section of Tilray's website at www.Tilray.com. About Tilray Bran

      3/27/25 4:30:00 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Reports Q2 2025 Financial Results

      Gross Profit Increased by 29% Year-Over-Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net Revenue of $211 Million, 10% in Constant Currency Beverage Revenue Increase by 36%, International Cannabis by 25%, Wellness Segment by 13% Announces Project 420: A $25 Million Synergy Plan for Tilray Beverage Business Tilray Reaffirms Fiscal Year 2025 Guidance Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods co

      1/10/25 7:00:50 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Moves Earnings Date to January 10, 2025, in Observance of the National Day of Mourning

      NEW YORK and LEAMINGTON, Ontario, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will now release its financial results for the second quarter ended November 30, 2024, before the financial market opens on January 10, 2025. The Company originally scheduled the release of its second quarter financial results before market open on January 9, 2025. This change reflects the observance of the National Day of Mourning in honor of former President Jimmy Carter. Live Conference Call and Audio Webcast Tilray will host a live conference call, w

      1/2/25 5:47:32 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands, Inc. to Announce Second Quarter Fiscal Year 2025 Financial Results on January 9, 2025

      NEW YORK and LEAMINGTON, Ontario, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will release its financial results for the second quarter ended November 30, 2024 before the financial market opens on January 9, 2025. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 a.m. Eastern Time. The webcast can be accessed on the Investors section of Tilray's website at www.Tilray.com. About Tilray Brands Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY

      12/19/24 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Reports Q1 2025 Financial Results

      Tilray Achieves 13% Year-Over-Year Growth, Generating Record Q1 Net Revenue of $200 Million Q1 Gross Margin Increases Over 500 Basis Points, Representing 20% Year-Over-Year Growth Tilray Beverages Achieves 132% Net Revenue Growth, Tilray Alternative Beverages Launched in October to Fuel Key U.S. Markets with Hemp-Derived Delta-9 THC Products German Medical Cannabis Flower Revenue Increases by 50% Following Legalization Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, tod

      10/10/24 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2025 Financial Results on October 10, 2024

      NEW YORK and LEAMINGTON, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will release its financial results for the first quarter which ended August 31, 2024 before the financial market opens on October 10, 2024. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 am Eastern Time. The webcast can be accessed on the Investors section of Tilray's website at www.Tilray.com. Investor Q&A Tilray Brands stockholders can submit and upvote question

      9/30/24 3:39:10 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results

      Achieved Net Revenue of $188 Million, ~ 30% Net Revenue Growth Over the Prior Year Quarter Beverage-Alcohol Net Revenue Increases 165% Over the Prior Year Quarter, 5th Largest Craft Beer Brewer in the U.S.1 with 4.5% Craft Beer Market Share Global Cannabis Net Revenue Increases 33% with International Cannabis Growth of 44% Over the Prior Year Quarter, #1 Market Share in Canada and #1 Market Share in Germany U.S. Cannabis Strategy in Place to Strike with Potential Drug Policy Reform Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, April 09, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a

      4/9/24 7:00:00 AM ET
      $BUD
      $TLRY
      Beverages (Production/Distribution)
      Consumer Staples
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Delivers Record Q2 Fiscal 2024 Net Revenue

      Record Q2 Net Revenue of $194 Million, Increases 34% Over the Prior Year Period Global Cannabis Leader with #1 Market Share in Canada and 31% Growth in Canadian Cannabis Net Revenue, Medical Cannabis Leader in Europe with 55% Growth in International Cannabis Net Revenue 5th Largest Craft Beer Brewer in the U.S.1, Positioned to Become Top 12 Beverage-Alcohol Company with 117% Increase in Beverage Alcohol Net Revenue Over the Prior Year Period On Track to Achieve $30-$35 Million in Annual Savings related to Integration of HEXO Acquisition Reiterates Financial Guidance for Fiscal Year 2024 Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Jan. 09, 2024 (

      1/9/24 7:00:00 AM ET
      $BUD
      $TLRY
      Beverages (Production/Distribution)
      Consumer Staples
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Reports Q1 2024 Financial Results

      Record Q1 Net Revenue of $177 Million, Representing 15% Growth Year over Year Increased #1 Cannabis Market Share Position in Canada to 13.4% Grew Canadian Cannabis Revenue by 16.5% and International Cannabis Revenue by 37% With Closing of Acquisition of Eight Craft Beer and Beverage Brands, Creating 5th Largest U.S. Craft Beer Brewer with 5% Market Share in Growing Craft Market Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today reported financial results for

      10/4/23 7:00:00 AM ET
      $BUD
      $TLRY
      Beverages (Production/Distribution)
      Consumer Staples
      Medicinal Chemicals and Botanical Products
      Health Care

    Tilray Brands Inc. SEC Filings

    See more
    • SEC Form DEFA14A filed by Tilray Brands Inc.

      DEFA14A - Tilray Brands, Inc. (0001731348) (Filer)

      4/28/25 4:55:34 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form DEF 14A filed by Tilray Brands Inc.

      DEF 14A - Tilray Brands, Inc. (0001731348) (Filer)

      4/28/25 4:53:44 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

      8-K - Tilray Brands, Inc. (0001731348) (Filer)

      4/25/25 4:06:00 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form PRE 14A filed by Tilray Brands Inc.

      PRE 14A - Tilray Brands, Inc. (0001731348) (Filer)

      4/17/25 8:32:23 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Tilray Brands, Inc. (0001731348) (Filer)

      4/17/25 7:42:47 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 10-Q filed by Tilray Brands Inc.

      10-Q - Tilray Brands, Inc. (0001731348) (Filer)

      4/8/25 5:01:26 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Tilray Brands, Inc. (0001731348) (Filer)

      4/8/25 7:00:13 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Tilray Brands, Inc. (0001731348) (Filer)

      3/25/25 4:35:08 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

      8-K - Tilray Brands, Inc. (0001731348) (Filer)

      3/10/25 5:06:56 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Tilray Brands, Inc. (0001731348) (Filer)

      2/26/25 4:34:30 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care